Celladon Corporation to Present at Credit Suisse Healthcare Conference
November 07, 2014 16:05 ET
|
Celladon Corporation
SAN DIEGO, Nov. 7, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene...
Celladon Corporation to Present at Credit Suisse Healthcare Investor Conference
November 05, 2014 16:15 ET
|
Celladon Corporation
SAN DIEGO, Nov. 5, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene...
Lonza and Celladon Corporation Establish a Strategic Commercial Manufacturing Collaboration for MYDICAR(R)
November 03, 2014 06:00 ET
|
Celladon Corporation
Agreement enhances existing relationship between Celladon and Lonza for the manufacture of MYDICAR®
Lonza to initiate design of a new commercial viral therapeutics facility in...
Celladon Corporation Announces Publication of Data From Its Stem Cell Factor Gene Therapy Program in Circulation Heart Failure
October 27, 2014 07:00 ET
|
Celladon Corporation
SAN DIEGO, Oct. 27, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a biotechnology industry leader in the field of cardiovascular gene therapy, today announced together with researchers...
Celladon to Present at the 2014 Stem Cell Meeting on the Mesa
October 01, 2014 16:15 ET
|
Celladon Corporation
SAN DIEGO, Oct. 1, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company applying its leadership position in the field of gene therapy and calcium...
Celladon Corporation Appoints Scott Garrett Vice President, Commercial Planning
September 22, 2014 08:00 ET
|
Celladon Corporation
SAN DIEGO, Sept. 22, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company applying its leadership position in the field of gene therapy and calcium...
Celladon Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares
August 18, 2014 16:05 ET
|
Celladon Corporation
SAN DIEGO, Aug. 18, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company applying its leadership position in the field of gene therapy and calcium...
Celladon Announces Pricing of Public Offering of Common Stock
August 12, 2014 18:06 ET
|
Celladon Corporation
SAN DIEGO, Aug. 12, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company applying its leadership position in the field of gene therapy and calcium...
Celladon Announces Initiation of Clinical Trial to Investigate MYDICAR in Patients With Heart Failure and a Left Ventricular Assist Device (LVAD)
August 11, 2014 04:00 ET
|
Celladon Corporation
SAN DIEGO, Aug. 11, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company applying its leadership position in the field of gene therapy and calcium...
Celladon Reports Second Quarter 2014 Financial Results and Recent Highlights
August 07, 2014 06:31 ET
|
Celladon Corporation
SAN DIEGO, Aug. 7, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company applying its leadership position in the field of gene therapy and calcium...